LG
ZBH icon

LaFleur & Godfrey’s Zimmer Biomet ZBH Stock Holding History

LaFleur & Godfrey’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,088
Closed -$236K – 150
2025
Q1 		$236K Hold
2,088
– – 0.03% 134
2024
Q4 		$221K Hold
2,088
– – 0.03% 140
2024
Q3 		$225K Sell
2,088
-300
-13% -$32.7K 0.03% 135
2024
Q2 		$259K Hold
2,388
– – 0.04% 123
2024
Q1 		$315K Sell
2,388
-400
-14% -$50K 0.05% 111
2023
Q4 		$339K Sell
2,788
-1,772
-39% -$198K 0.05% 101
2023
Q3 		$512K Sell
4,560
-16
-0.3% -$2.03K 0.08% 87
2023
Q2 		$666K Hold
4,576
– – 0.1% 83
2023
Q1 		$591K Sell
4,576
-133
-3% -$16.7K 0.1% 87
2022
Q4 		$600K Sell
4,709
-1,274
-21% -$148K 0.1% 87
2022
Q3 		$626K Sell
5,983
-3,688
-38% -$405K 0.11% 84
2022
Q2 		$1.02M Sell
9,671
-7,487
-44% -$888K 0.16% 80
2022
Q1 		$2.19M Sell
17,158
-4,587
-21% -$553K 0.29% 69
2021
Q4 		$2.68M Sell
21,745
-5,761
-21% -$754K 0.34% 65
2021
Q3 		$3.91M Sell
27,506
-14,770
-35% -$2.17M 0.54% 55
2021
Q2 		$6.6M Sell
42,276
-219
-0.5% -$35.5K 0.94% 37
2021
Q1 		$6.6M Buy
42,495
+792
+2% +$123K 1.29% 32
2020
Q4 		$6.24M Buy
41,703
+3,351
+9% +$473K 1.28% 31
2020
Q3 		$5.07M Sell
38,352
-742
-2% -$96.9K 1.14% 32
2020
Q2 		$4.53M Buy
39,094
+711
+2% +$81.9K 1.16% 32
2020
Q1 		$3.77M Sell
38,383
-77
-0.2% -$10.1K 1.12% 32
2019
Q4 		$5.59M Sell
38,460
-2,441
-6% -$337K 1.26% 31
2019
Q3 		$5.45M Buy
40,901
+963
+2% +$124K 1.34% 31
2019
Q2 		$4.57M Buy
39,938
+2,528
+7% +$296K 1.14% 33
2019
Q1 		$4.64M Buy
37,410
+3,023
+9% +$344K 1.2% 33
2018
Q4 		$3.46M Sell
34,387
-654
-2% -$73.5K 0.98% 36
2018
Q3 		$4.47M Buy
35,041
+479
+1% +$57K 1.08% 33
2018
Q2 		$3.74M Buy
+34,562
New +$3.76M 0.93% 37

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

LaFleur & Godfrey's ZBH Position: Q2 2025 in Review

LaFleur & Godfrey sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 2,088 shares — an estimated $236K sold.

LaFleur & Godfrey first reported a position in ZBH in Q2 2018 and held it in 28 quarters. The position peaked at $6.6M in Q1 2021. 936 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • LaFleur & Godfrey reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • LaFleur & Godfrey sold 2,088 Zimmer Biomet shares in Q2 2025, an estimated $236K.
  • LaFleur & Godfrey first reported a position in Zimmer Biomet in Q2 2018 and held it in 28 quarters.
  • LaFleur & Godfrey's Zimmer Biomet position peaked at $6.6M in Q1 2021.
  • 936 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on LaFleur & Godfrey's 13F filing for Q2 2025, filed 14 Jul 2025.